Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Jul 24, 2025; 16(7): 107339
Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.107339
Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.107339
Key players in the breast cancer microenvironment: From fibroblasts to immune cells
Sacide Çakal, Buket Er Urgancı, Selda Şimşek, Department of Medical Biology, Pamukkale University, Faculty of Medicine, Denizli 20070, Türkiye
Author contributions: Çakal S performed the majority of the writing; Urgancı BE and Şimşek S prepared and designed the outline and coordinated the writing of the paper.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sacide Çakal, MSc, Department of Medical Biology, Pamukkale University, Faculty of Medicine, Morphology Building, Floor:3, Denizli, 20070 Türkiye. scakal21@posta.pau.edu.tr
Received: April 1, 2025
Revised: April 21, 2025
Accepted: June 3, 2025
Published online: July 24, 2025
Processing time: 115 Days and 20.2 Hours
Revised: April 21, 2025
Accepted: June 3, 2025
Published online: July 24, 2025
Processing time: 115 Days and 20.2 Hours
Core Tip
Core Tip: The tumor microenvironment (TME) in breast cancer is a complex and dynamic ecosystem consisting of immune cells, stromal components, and the extracellular matrix. This review investigates how key players in the TME, including cancer-associated fibroblasts, tumor-infiltrating lymphocytes, and macrophages, contribute to tumor progression, immune modulation, and metastasis. Understanding these interactions sheds light on the mechanisms driving breast cancer heterogeneity and disease progression.